BCAL Diagnostics (ASX:BDX) Beginning Cash Position : A$3.17 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Beginning Cash Position?

BCAL Diagnostics's Beginning Cash Position for the quarter that ended in Dec. 2023 was A$3.17 Mil.

BCAL Diagnostics's quarterly Beginning Cash Position increased from Dec. 2022 (A$5.57 Mil) to Jun. 2023 (A$6.83 Mil) but then declined from Jun. 2023 (A$6.83 Mil) to Dec. 2023 (A$3.17 Mil).

BCAL Diagnostics's annual Beginning Cash Position increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$3.41 Mil) and increased from Jun. 2022 (A$3.41 Mil) to Jun. 2023 (A$5.57 Mil).

BCAL Diagnostics Beginning Cash Position Historical Data

The historical data trend for BCAL Diagnostics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Beginning Cash Position Chart

BCAL Diagnostics Annual Data

Trend

Jun22

Jun23

Beginning Cash Position

3.41

5.57

BCAL Diagnostics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial			3.41	4.39	5.57	6.83	3.17

BCAL Diagnostics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

BCAL Diagnostics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

BCAL Diagnostics (ASX:BDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230

Website

https://www.bcaldiagnostics.com

BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.